PROFILE H2020

The ‘PROFILE’ Innovative Trainning Network aims at stratifying acquired thrombotic thrombocytopenic purpura #TTP. #H2020 #HORIZON2020 #EU

[Jan Voorberg @VoorbergJ]

Congratulations Johana Hridinova with an excellent #PhD defence! Very nice discussions on etiology and treatment of iTTP @ITN_Profile @UvA_Amsterdam @MaastrichtUMC @sanquin @KU_Leuven

[Jan Voorberg @VoorbergJ]

Thanks Marie Scully for highlighting our paper on #ADAMTS13 #TTP @ITNProfile @KULeuvenKulak @icosagen Transforming the major autoantibody site on ADAMTS13: spacer domain variants retaining von Willebrand factor cleavage activity | Haematologica https://t.co/4KJ0tslhoS

[RPTH @RPTHjournal]

6 non-overlapping fragments of ADAMTS13 were used to develop and validate a fine epitope mapping ELISA of autoantbodies in iTTP. This high-throughput assay may be used in future clinical studies. Read more at #RPTH: https://t.co/qgFr941coY @kvhoorel @KU_Leuven @VoorbergJ

[RPTH @RPTHjournal]

Currently-published epitope mapping data of anti-ADAMTS13 autoantibodies in iTTP is broad due to the use of large protein fragments. Learn how @kvhoorel and colleagues fine-mapped these epitopes in 18 patients with iTTP. Results ➡️ https://t.co/qgFr94iNgw @KU_Leuven @VoorbergJ

[Jan Voorberg @VoorbergJ]

Very well moderated Q&A session by Ilaria Mancini on the session of Thrombotic Microangiopathies at @ISTH. @BogacErcig @kvhoorel @ITN_PROFILE

[Jan Voorberg @VoorbergJ]

Great collaborative work by the Vanhoorelbeke-team @KULeuvenKulak and Andres Mannik's cloning factory @icosagen. Nicely executed by star PhD student Kadri Kangro of @ITN_PROFILE https://t.co/XZLLpvrs6V

[X. Long Zheng, MD, PhD @DrXLongZheng]

COVID19 and TTP - TTP Network https://t.co/Mql5bIX2f5

[PROFILE H2020 @ITN_PROFILE]

A lovely #RareDiseaseDay for the #WalkForTTP. @Thrombosis_Lab @KULeuvenKulak @stadkortrijk @azgroeninge @RodeKruisVL @SanofiGenzyme @UZLeuven @KU_Leuven

[PROFILE H2020 @ITN_PROFILE]

The major from @stadkortrijk Vincent Van Quickenborne, supporting the #WalkForTTP initiative from the #ttpcommunity. @Thrombosis_Lab #rarediseaseday2020

[PROFILE H2020 @ITN_PROFILE]

Vicerector Piet Desmet from @KULeuvenKulak telling the #ttpcommunity “You never walk alone”. @Thrombosis_Lab #rarediseaseday2020

[PROFILE H2020 @ITN_PROFILE]

The voice of the patients #ttpcommunity #RareDiseaseDay

[PROFILE H2020 @ITN_PROFILE]

Prof. Karen Vanhoorelbeke from @Thrombosis_Lab giving an overview about research on TTP. @KULeuvenKulak #rarediseaseday2020

[PROFILE H2020 @ITN_PROFILE]

A closer look of the blood. #ttpcommunity #RareDiseaseDay @KULeuvenKulak

[PROFILE H2020 @ITN_PROFILE]

Listening to testimonies from patients from the #ttpcommunity, researchers, and physicians. #RareDiseaseDay @azgroeninge

[PROFILE H2020 @ITN_PROFILE]

Here is where TTP patients receive their therapy. #ttpcommunity #RareDiseaseDay @azgroeninge

[PROFILE H2020 @ITN_PROFILE]

We do not know how strong we are until being strong is your only choice. #ttpcommunity #rarediseaseday @azgroeninge

[PROFILE H2020 @ITN_PROFILE]

We are starting our #walkforttp celebrating #rarediseaseday. @KULeuvenKulak @azgroeninge @RodeKruisVL @SanofiGenzyme @stadkortrijk

[PROFILE H2020 @ITN_PROFILE]

TODAY!!! #RareDiseaseDay show your rare, show you care. Join the #WalkForTTP. From @KULeuvenKulak to @azgroeninge.

[DIATECH 2020 @DIATECH2020]

We're closing #DIATECH2020 with a visit to the @LeuvenU library. Thank you all for a nice conference and see you next time! #Leuven

[BIOSYSTEMS Department -KU Leuven @biosystkuleuven]

In vitro #diagnostics very slow in entering the market. WHY? Delays go about upscaling difficulties, risk & profit, complexity of biology. ‘And probably we need more #women in the field too!’, says professor Joanne Macdonald, the only female at the panel discussion @DIATECH2020